METLIFE INC Form SCHEDULE 13D/A — Nov 5, 2026
MetLife's Board of Directors filed Amendment No. 107 to Schedule 13D reporting beneficial ownership of 100,527,578 shares, or 16.0% of MetLife's outstanding common stock, held through the MetLife Policyholder Trust established under the 1999 Plan of Reorganization. Since the last amendment (July 31, 2026), beneficiary withdrawals and escheatments reduced Trust holdings from 102,098,469 to 100,527,578 shares, continuing the long-running decline from the 494,466,664 shares issued to the Trust in April 2000. The Board directs voting of these Trust shares on most matters, though beneficiaries vote individually on contested director elections, mergers, and other Beneficiary Consent Matters.
Key figures
- Shares Outstanding
- 16.0% of outstanding common stock beneficially owned by the Board via the Trust
- Amendment number
- 107
- Shares beneficially owned
- 100527578
- Prior shares held by trust
- 102098469
- Original shares issued to trust
- 494466664
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.